{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:08:49Z","timestamp":1780603729124,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impaired bone health is a common morbidity in Rett syndrome (RTT). We aimed to assess lumbar bone mineral density (BMD) and trabecular bone score (TBS) in females with RTT, and to evaluate the effectiveness of bisphosphonate treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 40 females with RTT, aged 5\u201322 years, who underwent dual-energy X-ray absorptiometry (DXA) scans during 2019\u20132024 at a national center for RTT. Data collected included medical treatment, anthropometric measurements, and functional scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age at the first DXA scan was 10.8 years. The mean L1\u20134 BMD Z-score was \u22122.1\u2009\u00b1\u20091.4, and the mean TBS Z-score was \u22120.4\u2009\u00b1\u20091.3. The L1\u20134 BMD Z-score correlated with height (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.407,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), weight (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.551,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), BMI (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.644,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and TBS Z-scores (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.594,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). Poor L1\u20134 BMD Z-scores were associated with poor mobility scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05) and valproate treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). Nine patients (23%) received zoledronate, for a mean 2 years. The mean age at zoledronate initiation was 9.7\u2009\u00b1\u20092.3 years. Four completed two DXA scans (pre- and post-treatment); the mean BMD Z-score improved from \u22122.2\u2009\u00b1\u20090.9 to \u22121.4\u2009\u00b1\u20090.9 after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Females with RTT have reduced lumbar BMD, which was associated with anthropometric factors, TBS, mobility, and valproate use. Zoledronate may be effective for some patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>In a retrospective study of 40 females with Rett syndrome (RTT), low bone mineral density (BMD) correlated with lower anthropometric measurements, impaired mobility, and valproic acid use.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The association between BMD and trabecular bone score (TBS) in the context of RTT is a novel finding.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Our preliminary data support the effectiveness and safety of zoledronate for treating osteoporosis in patients with RTT.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Our findings are important in light of the increasing life expectancy of individuals with RTT, and the consequent need to prioritize bone health in this population.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04001-4","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:27:32Z","timestamp":1742585252000},"page":"1870-1875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone health and bisphosphonate treatment in females with Rett syndrome in a national center"],"prefix":"10.1038","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-4230","authenticated-orcid":false,"given":"Yael","family":"Levy-Shraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Tripto-Shkolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalit","family":"Modan-Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Givon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruria","family":"Ben-Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"4001_CR1","volume":"23","author":"D May","year":"2023","unstructured":"May, D. et al. Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study. BMC Neurol. 23, 141 (2023).","journal-title":"BMC Neurol."},{"key":"4001_CR2","doi-asserted-by":"crossref","unstructured":"Kyle S. M., Vashi N., Justice M. J. Rett syndrome: a neurological disorder with metabolic components. Open Biol. 8, 170216 (2018).","DOI":"10.1098\/rsob.170216"},{"key":"4001_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","volume":"19","author":"JPK Ip","year":"2018","unstructured":"Ip, J. P. K., Mellios, N. & Sur, M. Rett syndrome: insights into genetic, molecular and circuit mechanisms. Nat. Rev. Neurosci. 19, 368\u2013382 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"4001_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet 23, 185\u2013188 (1999).","journal-title":"Nat. Genet"},{"key":"4001_CR5","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1097\/BSD.0000000000001381","volume":"36","author":"S Menachem","year":"2023","unstructured":"Menachem, S. et al. Scoliosis in RETT syndrome: a national referral centre experience. Clin. Spine Surg. 36, E75\u2013E79 (2023).","journal-title":"Clin. Spine Surg."},{"key":"4001_CR6","doi-asserted-by":"crossref","first-page":"e800","DOI":"10.1097\/BPO.0000000000001898","volume":"41","author":"B Kanashvili","year":"2021","unstructured":"Kanashvili, B. et al. Hip displacement in MECP2 disorders: prevalence and risk factors. J. Pediatr. Orthop. 41, e800\u2013e803 (2021).","journal-title":"J. Pediatr. Orthop."},{"key":"4001_CR7","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/jbmr.423","volume":"26","author":"G Roende","year":"2021","unstructured":"Roende, G. et al. DXA measurements in Rett syndrome reveal small bones with low bone mass. J. Bone Min. Res. 26, 2280\u20132286 (2021).","journal-title":"J. Bone Min. Res"},{"key":"4001_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1203\/PDR.0b013e31820b937d","volume":"69","author":"AL Jefferson","year":"2011","unstructured":"Jefferson, A. L. et al. Bone mineral content and density in Rett syndrome and their contributing factors. Pediatr. Res. 69, 293\u2013298 (2011).","journal-title":"Pediatr. Res"},{"key":"4001_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bone.2015.01.023","volume":"74","author":"A Jefferson","year":"2015","unstructured":"Jefferson, A. et al. Longitudinal bone mineral content and density in Rett syndrome and their contributing factors. Bone 74, 191\u2013198 (2015).","journal-title":"Bone"},{"key":"4001_CR10","doi-asserted-by":"crossref","unstructured":"Pecorelli A. et al. Altered bone status in rett syndrome. Life (Basel) 11, 521 (2021).","DOI":"10.3390\/life11060521"},{"key":"4001_CR11","doi-asserted-by":"crossref","unstructured":"Caffarelli C. et al. Bone fracture in rett syndrome: mechanisms and prevention strategies. Children (Basel) 10, 1861 (2023).","DOI":"10.3390\/children10121861"},{"key":"4001_CR12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1542\/peds.2007-1641","volume":"121","author":"J Downs","year":"2008","unstructured":"Downs, J. et al. Early determinants of fractures in Rett syndrome. Pediatrics 121, 540\u2013546 (2008).","journal-title":"Pediatrics"},{"key":"4001_CR13","first-page":"446","volume":"68","author":"JR Shapiro","year":"2010","unstructured":"Shapiro, J. R. et al. Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations. Pediatr. Res. 68, 446\u2013451 (2010).","journal-title":"Pediatr. Res"},{"key":"4001_CR14","volume":"21","author":"C Caffarelli","year":"2021","unstructured":"Caffarelli, C. et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome. BMC Med Genet 21, 21 (2021).","journal-title":"BMC Med Genet"},{"key":"4001_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva, B. C. et al. Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. J. Clin. Densitom. 18, 309\u2013330 (2015).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva, B. C. et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J. Bone Min. Res. 29, 518\u2013530 (2014).","journal-title":"J. Bone Min. Res"},{"key":"4001_CR17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jocd.2019.07.006","volume":"22","author":"K Krohn","year":"2019","unstructured":"Krohn, K. et al. Dual-energy X-ray Absorptiometry Monitoring with Trabecular Bone Score: 2019 ISCD Official Position. J. Clin. Densitom. 22, 501\u2013505 (2019).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jbmr.3124","volume":"32","author":"P Martineau","year":"2017","unstructured":"Martineau, P. et al. Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: the manitoba BMD cohort. J. Bone Min. Res. 32, 1568\u20131574 (2017).","journal-title":"J. Bone Min. Res"},{"key":"4001_CR19","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.clnu.2018.04.013","volume":"38","author":"Y Levy-Shraga","year":"2019","unstructured":"Levy-Shraga, Y. et al. Low trabecular bone score in adolescent female inpatients with anorexia nervosa. Clin. Nutr. 38, 1166\u20131170 (2019).","journal-title":"Clin. Nutr."},{"key":"4001_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jocd.2020.10.008","volume":"24","author":"Y Levy-Shraga","year":"2021","unstructured":"Levy-Shraga, Y. et al. Trabecular bone score in children and adolescents with inflammatory bowel diseases. J. Clin. Densitom. 24, 243\u2013251 (2021).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR21","doi-asserted-by":"crossref","first-page":"e0290812","DOI":"10.1371\/journal.pone.0290812","volume":"18","author":"Y Ohata","year":"2023","unstructured":"Ohata, Y. et al. Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study. PLoS One 18, e0290812 (2023).","journal-title":"PLoS One"},{"key":"4001_CR22","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-023-01291-1","volume":"18","author":"MM Fraga","year":"2023","unstructured":"Fraga, M. M. et al. Trabecular bone score (TBS) and bone mineral density (BMD) analysis by dual X-ray absorptiometry (DXA) in healthy Brazilian children and adolescents: normative data. Arch. Osteoporos. 18, 82 (2023).","journal-title":"Arch. Osteoporos."},{"key":"4001_CR23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jbmr.4520","volume":"37","author":"HJ Kalkwarf","year":"2022","unstructured":"Kalkwarf, H. J. et al. Trabecular bone score reference values for children and adolescents according to age, sex, and ancestry. J. Bone Min. Res. 37, 776\u2013785 (2022).","journal-title":"J. Bone Min. Res."},{"key":"4001_CR24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"JL Neul","year":"2010","unstructured":"Neul, J. L. et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944\u2013950 (2010).","journal-title":"Ann. Neurol."},{"key":"4001_CR25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","volume":"39","author":"R Palisano","year":"1997","unstructured":"Palisano, R. et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med Child Neurol. 39, 214\u2013223 (1997).","journal-title":"Dev. Med Child Neurol."},{"key":"4001_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01241398-200409000-00011","volume":"24","author":"HK Graham","year":"2004","unstructured":"Graham, H. K. et al. The Functional Mobility Scale (FMS). J. Pediatr. Orthop. 24, 514\u2013520 (2004).","journal-title":"J. Pediatr. Orthop."},{"key":"4001_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","volume":"17","author":"CM Gordon","year":"2014","unstructured":"Gordon, C. M. et al. 2013 Pediatric Position Development Conference: executive summary and reflections. J. Clin. Densitom. 17, 219\u2013224 (2014).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree, N. J. et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J. Clin. Densitom. 17, 225\u2013242 (2014).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"DR Carter","year":"1992","unstructured":"Carter, D. R., Bouxsein, M. L. & Marcus, R. New approaches for interpreting projected bone densitometry data. J. Bone Min. Res. 7, 137\u2013145 (1992).","journal-title":"J. Bone Min. Res"},{"key":"4001_CR30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jbmr.2935","volume":"32","author":"NJ Crabtree","year":"2017","unstructured":"Crabtree, N. J. et al. Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults-the ALPHABET Study. J. Bone Min. Res. 32, 172\u2013180 (2017).","journal-title":"J. Bone Min. Res"},{"key":"4001_CR31","unstructured":"Del Rio L., et al. Bone microarchitecture (TBS) and bone mass development during childhood and adolescence in a Spanish population group. ECCEO-IOF Congress, Sevilla, Spain. 2014)."},{"key":"4001_CR32","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-9-87","volume":"9","author":"A Anderson","year":"2014","unstructured":"Anderson, A. et al. Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J. Rare Dis. 9, 87 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"4001_CR33","doi-asserted-by":"crossref","first-page":"e0146824","DOI":"10.1371\/journal.pone.0146824","volume":"11","author":"A Jefferson","year":"2016","unstructured":"Jefferson, A. et al. Clinical guidelines for management of bone health in rett syndrome based on expert consensus and available evidence. PLoS One 11, e0146824 (2016).","journal-title":"PLoS One"},{"key":"4001_CR34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1203\/PDR.0b013e318180ebcd","volume":"64","author":"KJ Motil","year":"2008","unstructured":"Motil, K. J. et al. Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr. Res. 64, 435\u2013439 (2008).","journal-title":"Pediatr. Res"},{"key":"4001_CR35","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s00198-002-1345-4","volume":"14","author":"P Ammann","year":"2003","unstructured":"Ammann, P. & Rizzoli, R. Bone strength and its determinants. Osteoporos. Int 14, S13\u2013S18 (2003).","journal-title":"Osteoporos. Int"},{"key":"4001_CR36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jocd.2020.10.011","volume":"24","author":"EW Gripp","year":"2021","unstructured":"Gripp, E. W. et al. A Comparison of Lumbar Spine and Lateral Distal Femur Bone Density in Girls With Rett Syndrome. J. Clin. Densitom. 24, 374\u2013382 (2021).","journal-title":"J. Clin. Densitom."},{"key":"4001_CR37","doi-asserted-by":"crossref","unstructured":"Tsaknakis K., et al. Reduced Volumetric Bone Mineral Density of the Spine in Adolescent Rett Girls with Scoliosis. Children (Basel) 9 (2022).","DOI":"10.3390\/children9121902"},{"key":"4001_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12887-020-1984-7","volume":"20","author":"L Min","year":"2020","unstructured":"Min, L., Chunyan, W. & Biaoxue, R. Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies. BMC Pediatr. 20, 97 (2020).","journal-title":"BMC Pediatr."},{"key":"4001_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2015.01.024","volume":"76","author":"ME Blue","year":"2015","unstructured":"Blue, M. E. et al. Osteoblast function and bone histomorphometry in a murine model of Rett syndrome. Bone 76, 23\u201330 (2015).","journal-title":"Bone"},{"key":"4001_CR40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bone.2014.10.008","volume":"71","author":"B Kamal","year":"2015","unstructured":"Kamal, B. et al. Biomechanical properties of bone in a mouse model of Rett syndrome. Bone 71, 106\u2013114 (2015).","journal-title":"Bone"},{"key":"4001_CR41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bone.2009.04.251","volume":"45","author":"RD O\u2019Connor","year":"2009","unstructured":"O\u2019Connor, R. D. et al. Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone 45, 346\u2013356 (2009).","journal-title":"Bone"},{"key":"4001_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.03.040","volume":"99","author":"JR Shapiro","year":"2017","unstructured":"Shapiro, J. R. et al. Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome. Bone 99, 1\u20137 (2017).","journal-title":"Bone"},{"key":"4001_CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1203\/PDR.0b013e31820bc6d3","volume":"69","author":"G Roende","year":"2011","unstructured":"Roende, G. et al. Patients with Rett syndrome sustain low-energy fractures. Pediatr. Res, 69, 359\u2013364 (2011).","journal-title":"Pediatr. Res"},{"key":"4001_CR44","doi-asserted-by":"crossref","unstructured":"Frullanti E. et al. Analysis of the phenotypes in the Rett networked database. Int. J. Genomics, 2019, 6956934 (2019).","DOI":"10.1155\/2019\/6956934"},{"key":"4001_CR45","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","volume":"70","author":"A Bebbington","year":"2008","unstructured":"Bebbington, A. et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology 70, 868\u2013875 (2008).","journal-title":"Neurology"},{"key":"4001_CR46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2006.045260","volume":"44","author":"H Archer","year":"2007","unstructured":"Archer, H. et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J. Med Genet 44, 148\u2013152 (2007).","journal-title":"J. Med Genet"},{"key":"4001_CR47","doi-asserted-by":"crossref","first-page":"e0186941","DOI":"10.1371\/journal.pone.0186941","volume":"12","author":"AS Lambert","year":"2017","unstructured":"Lambert, A. S. et al. Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility. PLoS One 12, e0186941 (2017).","journal-title":"PLoS One"},{"key":"4001_CR48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00223-018-0505-2","volume":"104","author":"A Wiedemann","year":"2019","unstructured":"Wiedemann, A. et al. Annual injection of zoledronic acid improves bone status in children with cerebral palsy and Rett syndrome. Calcif. Tissue Int. 104, 355\u2013363 (2019).","journal-title":"Calcif. Tissue Int"},{"key":"4001_CR49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbmr.4786","volume":"38","author":"LF Valenzuela Riveros","year":"2023","unstructured":"Valenzuela Riveros, L. F. et al. Trabecular Bone Score (TBS) varies with correction for tissue thickness versus body mass index: implications when using pediatric reference norms. J. Bone Min. Res. 38, 493\u2013498 (2023).","journal-title":"J. Bone Min. Res"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04001-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:21:27Z","timestamp":1762881687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4001"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04001-4","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Sheba Medical Center. Informed consent was not required, as the data were deidentified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}